Clinical trials for advancing innovative interventions for neurodegenerative diseases

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities make effective use of state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to underpin and complement the development of innovative interventions aimed at more effective treatments for neurodegenerative diseases. The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond. The scientific and clinical communities make wide use… more

Brain researchClinical medicineClinical neurologyClinical researchClinical trialsCognition (e.g. learning, memory, emotions, speech)DementiaInterventional clinical trialsMolecular and cellular neuroscienceNeurobiologyNeurochemistry and neuropharmacologyNeurodegenerative disordersNeuroinflammatory disordersNeurological disorders (e.g. Alzheimer's disease, Huntington's disease, Parkinson's disease)NeurologyNeurosciences (including psychophysiology)

1. %99
   BAŞAR BİLGİÇ

   Profesörİstanbul Üniversitesi

   Shared topics: Parkinson's Disease Mechanisms and Treatments · Alzheimer's disease research and treatments · Neurological disorders and treatments · Genetic Neurodegenerative Diseases

2. %91
   BÜŞRA OKUYUCU

   Araştırma GörevlisiOndokuz Mayıs Üniversitesi

   Shared topics: Cholinesterase and Neurodegenerative Diseases · Neurological disorders and treatments

3. %91
   ERDEM ARSLAN

   Doktor Öğretim ÜyesiAksaray Üniversitesi

   Shared topics: Neuroinflammation and Neurodegeneration Mechanisms · Neurological diseases and metabolism

4. %91
   FATOŞ SİBEL ERTAN

   ProfesörKoç Üniversitesi

   Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments · Botulinum Toxin and Related Neurological Disorders · Genetic Neurodegenerative Diseases

5. %91
   TUĞBA RAİKA KIRAN

   ProfesörMalatya Turgut Özal Üniversitesi

   Shared topics: Neurological Disease Mechanisms and Treatments · COVID-19 Clinical Research Studies

6. %91
   ÖZGÜR ÖZTOP ÇAKMAK

   DoçentKoç Üniversitesi

   Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments · Genetic Neurodegenerative Diseases · Botulinum Toxin and Related Neurological Disorders

7. %90
   REZZAK YILMAZ

   DoçentAnkara Üniversitesi

   Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments · Botulinum Toxin and Related Neurological Disorders · Genetic Neurodegenerative Diseases

8. %90
   ÇİĞDEM SEVDA ERER ÖZBEK

   ProfesörBursa Uludağ Üniversitesi

   Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments · Botulinum Toxin and Related Neurological Disorders · Genetic Neurodegenerative Diseases

9. %89
   OKAN DOĞU

   ProfesörMersin Üniversitesi

   Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments · Botulinum Toxin and Related Neurological Disorders · Genetic Neurodegenerative Diseases

10. %88
    ELİF YILMAZ GÜLEÇ

    Doçentİstanbul Medeniyet Üniversitesi

    Shared topics: Genetics and Neurodevelopmental Disorders · Genetic and Kidney Cyst Diseases · Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities

11. %88
    EMRE UYGUR

    Doktor Öğretim ÜyesiManisa Celâl Bayar Üniversitesi

    Shared topics: Neurological disorders and treatments · Genetic Neurodegenerative Diseases

12. %88
    MUSTAFA NAMIK ÖZTANIR

    ProfesörBezm-İ Âlem Vakıf Üniversitesi

    Shared topics: Neurological Disease Mechanisms and Treatments · Neuroinflammation and Neurodegeneration Mechanisms · MicroRNA in disease regulation

13. %87
    HAMİYET ECİROĞLU SARBAN

    Doktor Öğretim ÜyesiAlanya Alaaddin Keykubat Üniversitesi

    Shared topics: Alzheimer's disease research and treatments · Cholinesterase and Neurodegenerative Diseases · Neuroinflammation and Neurodegeneration Mechanisms

14. %87
    SEBİLE KOCA

    Doktor Öğretim ÜyesiHaliç Üniversitesi

    Shared topics: Alzheimer's disease research and treatments · Neuroinflammation and Neurodegeneration Mechanisms

15. %86
    ÖNDER OTLU

    Doktor Öğretim ÜyesiMalatya Turgut Özal Üniversitesi

    Shared topics: Neurological Disease Mechanisms and Treatments · COVID-19 Clinical Research Studies

16. %85
    UĞUR ÖZBEK

    Öğretim Görevlisi (uygulamalı Birim)Sakarya Üniversitesi

    Shared topics: Genomics and Rare Diseases · Genetics and Neurodevelopmental Disorders

17. %84
    FATMA GONCA KOÇANCI

    DoçentAlanya Alaaddin Keykubat Üniversitesi

    Shared topics: Cholinesterase and Neurodegenerative Diseases · Alzheimer's disease research and treatments · Neuroinflammation and Neurodegeneration Mechanisms

18. %84
    FATİH TEPGEÇ

    Doktor Öğretim ÜyesiAltınbaş Üniversitesi

    Shared topics: Parkinson's Disease Mechanisms and Treatments · Neuroinflammation and Neurodegeneration Mechanisms

19. %84
    TAHİRE YURDAKUL

    Araştırma GörevlisiVan Yüzüncü Yıl Üniversitesi

    Shared topics: Alzheimer's disease research and treatments · Neuroinflammation and Neurodegeneration Mechanisms · Cholinesterase and Neurodegenerative Diseases

20. %83
    MELDA BOZLUOLCAY

    ProfesörBiruni Üniversitesi

    Shared topics: Alzheimer's disease research and treatments · Neurological and metabolic disorders

21. %83
    NEVRA ÖKSÜZ GÜRLEN

    DoçentMersin Üniversitesi

    Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments

22. %83
    YUNUS EMRE AKTAŞ

    Doktor Öğretim ÜyesiAtatürk Üniversitesi

    Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments

23. %83
    ZEYNEP TÜFEKÇİOĞLU KORKMAZ

    Doçentİstanbul Atlas Üniversitesi

    Shared topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments · RNA regulation and disease

24. %82
    DİLARA NEMUTLU SAMUR

    DoçentAlanya Alaaddin Keykubat Üniversitesi

    Shared topics: Neuroinflammation and Neurodegeneration Mechanisms · Parkinson's Disease Mechanisms and Treatments

25. %82
    GÖZDE YEŞİL SAYIN

    Profesörİstanbul Atlas Üniversitesi

    Shared topics: Genomics and Rare Diseases · Genetics and Neurodevelopmental Disorders · Glycogen Storage Diseases and Myoclonus · Hereditary Neurological Disorders

26. %82
    NAGEHAN ERSOY TUNALI

    Doçentİstanbul Medeniyet Üniversitesi

    Shared topics: Genetic Neurodegenerative Diseases · MicroRNA in disease regulation · Alzheimer's disease research and treatments

27. %82
    YEŞİM YENİ

    DoçentMalatya Turgut Özal Üniversitesi

    Shared topics: Cholinesterase and Neurodegenerative Diseases · MicroRNA in disease regulation

28. %81
    FATMA YILDIZ

    DoçentAlanya Alaaddin Keykubat Üniversitesi

    Shared topics: Cholinesterase and Neurodegenerative Diseases · Alzheimer's disease research and treatments

29. %81
    HATİCE DOĞAN GÖÇMEN

    Doktor Öğretim ÜyesiHatay Mustafa Kemal Üniversitesi

    Shared topics: Neurological Disease Mechanisms and Treatments

30. %80
    BURAK YULUĞ

    ProfesörAlanya Alaaddin Keykubat Üniversitesi

    Shared topics: Parkinson's Disease Mechanisms and Treatments · Alzheimer's disease research and treatments · Neurological disorders and treatments

The fit is computed by code on every request: semantic similarity (55%) between the call text (title, EU keywords, start of the official description) and the academic’s YÖKSİS fields, keywords and OpenAlex topics, plus shared distinctive terms (45%; common words weigh little). Below 40% is not shown. A subject hint only — not an eligibility, capacity or merit assessment. Hidden profiles are never listed.